Fate Therapeutics
FATE
#9044
Rank
S$0.16 B
Marketcap
S$1.40
Share price
-1.82%
Change (1 day)
-56.07%
Change (1 year)

Market capitalization of Fate Therapeutics (FATE)

Market cap: S$0.16 Billion

As of December 2025 Fate Therapeutics has a market cap of S$0.16 Billion. This makes Fate Therapeutics the world's 9044th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Fate Therapeutics from 2013 to 2025

End of year Market Cap

Year Marketcap Change
2025S$0.16 B-35.23%
2024S$0.24 B-48.82%
2023S$0.48 B-62.95%
2022S$1.31 B-82.6%
2021S$7.55 B-28.03%
2020S$10.49 B425.26%
2019S$1.99 B76.21%
2018S$1.13 B163.6%
2017S$0.43 B186.13%
2016S$0.15 B9.83%
2015S$0.13 B0.13%
2014S$0.13 B-15.91%
2013S$0.16 B

End of Day market cap according to different sources

On Dec 5th, 2025 the market cap of Fate Therapeutics was reported to be:

S$0.16 Billion
by Nasdaq info icon info icon
S$0.16 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sarepta Therapeutics
SRPT
S$3.02 B 1,772.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
S$72.04 B 44,525.18%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
S$8.03 B 4,878.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
S$13.98 B 8,563.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
S$20.09 B 12,345.96%๐Ÿ‡บ๐Ÿ‡ธ USA